Molecular Investigation of Genetic Predisposition to Renal Cancer

Medicine & Life Sciences

1. Renal Cell Carcinoma 100%
2. Familial renal cell carcinoma 85%
3. Mutation 83%
4. Ovarian Neoplasms 83%
5. Germ-Line Mutation 63%
6. Breast Neoplasms 49%
7. Neoplasms 40%
8. Chromosomes, Human, Pair 3 39%
9. Tumor Suppressor Genes 35%
10. Penetrance 33%
11. Succinate Dehydrogenase 32%
12. Genetic Services 32%
13. Modifier Genes 32%
14. Male Breast Neoplasms 31%
15. Methylation 28%
16. CpG Islands 26%
17. Genetic Testing 25%
18. Birt-Hogg-Dube Syndrome 22%
19. Life Expectancy 22%
20. Population 19%
21. Genes 19%
22. Pheochromocytoma 17%
23. Genotype 15%
24. Genome 15%
25. Paraganglioma 15%
26. Renal cell carcinoma 1 14%
27. Phenotype 13%
28. Kidney 13%
29. Chromosome Breakpoints 12%
30. von Hippel-Lindau Disease 12%
31. Fumarate Hydratase 11%
32. Somatostatin 11%
33. Immunohistochemistry 9%
34. SKP Cullin F-Box Protein Ligases 9%
35. Fluorescence In Situ Hybridization 9%
36. Neck 8%
37. Head 8%
38. Growth 8%
39. F-Box Proteins 8%
40. Ubiquitin-Conjugating Enzymes 8%
41. Down-Regulation 7%
42. Kaplan-Meier Estimate 7%
43. Familial Breast Cancer 7%
44. Chromosomes, Human, Pair 5 7%
45. Genomic Islands 7%
46. Demethylation 6%
47. Cell Line 6%
48. BRCA2 Gene 6%
49. Messenger RNA 6%
50. Ubiquitin-Protein Ligases 6%
51. Gene Deletion 6%
52. Poly(ADP-ribose) Polymerase Inhibitors 5%
53. Incidence 5%
54. Genetic Promoter Regions 5%
55. Carcinogens 5%
56. RNA Interference 5%
57. Cysteine 5%
58. Cytogenetic Analysis 5%
59. Actuarial Analysis 5%
60. Catalytic Domain 5%